NT

Nivenjeet Tiwari

Active Director Director DIN 02042777
DIN 02042777 First appointment Oct 2008 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 4 active board seats
Past companies 5 historical roles
Total affiliations 9 Since Oct 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Nivenjeet Tiwari

Data last updated:

Nivenjeet Tiwari is a Director at World Brain Center And Research Institute (since 2008), Director at Avni Tiwari Beyond Ordinary Media Private Limited (since 2026) and Director at Royal House Of Psychiatry Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Healthcare, Ecommerce and Internet and Business Services. The largest current company by reported revenue is World Brain Center And Research Institute at ₹10.79 Cr (FY 2025). Earlier, Nivenjeet Tiwari was a Director at Dorris Pharmaceuticals Private Limited (2013–2025) and Director at Mera Pharma Dot Com Private Limited (from 2009) and 3 more.

DIN 02042777
Primary Designation Director
Industry Healthcare
First Appointment 31 Oct 2008
Oldest Company Age 17 yrs
Largest company World Brain Center And Research Institute Β· ₹10.79 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Oct 20082008₹10.79 Cr (FY 2025)Active
Director06 Aug 20262026Active
Director21 Aug 20232023Active
Soulgate Education Private Limited U74999DL2016PTC299041
Director04 May 20162016Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Jun 20132009₹71.6 Lakh (FY 2024)Active
Mera Pharma Dot Com Private Limited U24231DL2009PTC188418
Director13 Mar 20092009Strike Off
Holy Herbs Private Limited U74140DL2013PTC258350
Director24 Sep 20132013Strike Off
Gaddiel Innovations Private Limited U74999DL2016PTC300156
Director23 May 20162016Strike Off
Director17 Oct 20222022Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Nivenjeet Tiwari

Directorship timeline

Open interactive timeline →
Mera Pharma Dot Com Private Limited
Holy Herbs Private Limited
Soulgate Education Private Limited
Gaddiel Innovations Private Limited
Premium access

Shareholding and investment profile for Nivenjeet Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nivenjeet Tiwari

Nivenjeet Tiwari currently holds 4 directorships: World Brain Center And Research Institute (Director, since 31 Oct 2008, revenue β‚Ή10.79 Cr (FY 2025)); Avni Tiwari Beyond Ordinary Media Private Limited (Director, since 06 Aug 2026); Royal House Of Psychiatry Private Limited (Director, since 21 Aug 2023); Soulgate Education Private Limited (Director, since 04 May 2016).

Nivenjeet Tiwari was first appointed on 31 Oct 2008 as Director at World Brain Center And Research Institute. The most recent appointment on record is 06 Aug 2026 at Avni Tiwari Beyond Ordinary Media Private Limited.

Nivenjeet Tiwari held 5 earlier board appointments: Dorris Pharmaceuticals Private Limited (Director, 17 Jun 2013 to 10 Apr 2025); Mera Pharma Dot Com Private Limited (Director, from 13 Mar 2009); Holy Herbs Private Limited (Director, from 24 Sep 2013); Gaddiel Innovations Private Limited (Director, from 23 May 2016); Bounce Back Global Health Private Limited (Director, from 17 Oct 2022).

The current boards of Nivenjeet Tiwari's companies include Neelesh Tiwari (World Brain Center And Research Institute), Avni Tiwari (Avni Tiwari Beyond Ordinary Media Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available